Viewing Study NCT02406092

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:17 PM

Ignite Modification Date: 2026-04-16 @ 1:07 PM

Study NCT ID: NCT02406092

Status: COMPLETED

Last Update Posted: 2024-11-21

First Post: 2015-03-23

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A

Sponsor: Hoffmann-La Roche

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module